NRXP NRX PHARMACEUTICALS INC Capital Structure Changes 8-K Filing 2024 - Financing Agreement NRx Pharmaceuticals entered into a Securities Purchase Agreement to sell up to $16.3 million in convertible promissory notes and warrants, and settled a prior obligation with Streeterville for $5.55 million.Get access to all SEC 8-K filings of the NRX PHARMACEUTICALS INC